Risk of Depression in the Mothers of Older Children
Many studies have assessed the risk of depression in the mothers of infants, but fewer studies have focused on the risk of depression in the mothers with older children.Â
Many studies have assessed the risk of depression in the mothers of infants, but fewer studies have focused on the risk of depression in the mothers with older children.Â
We write often here about the negative effects of postpartum depression on the child. Â Most of the studies thus far have focused on behavior and cognitive development; a recent study from researchers at JohnsHopkinsUniversity suggests that being exposed to maternal depression during the first year of life may negatively affect the physical development of the child as well.
Iodine is essential for thyroid hormone synthesis. We have known for a long time that severe iodine deficiency during pregnancy may affect the cognitive development of the unborn child. According to a recent Lancet study, even children born to women with mild-to-moderate iodine deficiency during pregnancy are at increased risk for lower IQ and reading ability (assessed at age 9). The most severe effects were observed among children born to women with severe deficiency (<50 mcg/g iodine:creatinine ratio).Â
It is estimated that autism spectrum disorders (ASD) affect about 1% to 2% of children. Research carried out in twins and families indicate that ASD is highly heritable; however, it is generally believed that while genetic factors play an important role, there is an interplay between genetic and environmental factors in the etiology of this disorder. Various environmental exposures have been implicated, including vaccinations, mercury, air pollution, insecticides, and infection.
There have been multiple recent reports indicating that the use of valproate during pregnancy may be associated with lower IQ, cognitive problems, and developmental delays in exposed children. This has prompted the FDA to issue a warning regarding the use of valproate-containing drugs, including Depakote and Depakene, during pregnancy:
While much research has demonstrated that maternal depression may negatively affect the child, leading to increased risk of developmental delays, behavioral problems, and psychiatric illness. Less research, however, has detailed the impact of paternal depression; several recent studies have focused on better understanding the risk factors for paternal depression and how paternal depression affects children.
Multiple studies have demonstrated that childhood maltreatment is associated with subsequent difficulties. Researchers from the University of Michigan assessed parenting behaviors in women with a history of childhood abuse and neglect (n?=?97) and a healthy control comparison group (n?=?53). Participants were assessed at 6 weeks, 4 months, and 6 months postpartum. At 6 months, a home visit was conducted and  mothers and infants participated in a dyadic play interaction later coded for positive parenting behaviors by blinded raters.
About 10-30% of children have functional somatic symptoms (FSS). These are physical complaints, such as headaches, pain, fatigue, and dizziness, that cannot be explained medically. A new study suggests that when a child is exposed to depression or anxiety in the mother during the first year of life, he or she is more likely to report these somatic symptoms later on.
Multiple studies have concluded that the children of depressed mothers are at increased risk for behavioral problems and other mental health issues.  Data from 7429 mother–child pairs participating in the Avon Longitudinal Study of Parents and Children in the UK indicate that maternal depression (assessed when the children were 1.5 year old) is associated with an increased risk of psychiatric diagnoses in the children at 7.5 years of age.
While many studies have looked at the impact of postpartum depression in mothers on their children, there is very limited data on postnatal depression in the fathers and the potential impact it may have on their children.